Ontology highlight
ABSTRACT: Objectives
Ki67 is the most commonly used marker to evaluate proliferative index in breast cancer, however no cutoff values have been clearly defined for high ki67 index. Cancer management should be according to loco-regional profile; therefore, we aimed to determine ki67 index in 1951 cases of intrinsic breast cancer subtypes and its association with other prognostic parameters in our set up.Results
Triple negative breast cancers showed highest ki67 index (mean 50.9 ± 23.7%) followed by Her2neu (mean 42.6 ± 21.6%) and luminal B cancers (mean 34.9 ± 20.05%). Metaplastic and medullary breast cancers significantly showed higher ki67 index as compared to ductal carcinoma, NOS. No significant association of ki67 index was noted with any of the histologic parameters in different subtypes of breast cancer expect for tumor grade. Although, ki67 index is a valuable biomarker in breast cancer, however no independent prognostic significance of ki67 could be established in our study.
SUBMITTER: Hashmi AA
PROVIDER: S-EPMC6755684 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature
Hashmi Atif Ali AA Hashmi Kashif Ali KA Irfan Muhammad M Khan Saadia Mehmood SM Edhi Muhammad Muzzammil MM Ali Javaria Parwez JP Hashmi Shumaila Kanwal SK Asif Huda H Faridi Naveen N Khan Amir A
BMC research notes 20190923 1
<h4>Objectives</h4>Ki67 is the most commonly used marker to evaluate proliferative index in breast cancer, however no cutoff values have been clearly defined for high ki67 index. Cancer management should be according to loco-regional profile; therefore, we aimed to determine ki67 index in 1951 cases of intrinsic breast cancer subtypes and its association with other prognostic parameters in our set up.<h4>Results</h4>Triple negative breast cancers showed highest ki67 index (mean 50.9 ± 23.7%) fol ...[more]